Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2013
12/31/2013US8617875 Expression vector suitable for expression of a coding sequence for gene therapy
12/31/2013US8617868 Asparaginase enzyme variants and uses thereof
12/31/2013US8617861 Method for producing butanol using extractive fermentation with electrolyte addition
12/31/2013US8617853 Ketoreductase polypeptides for the production of (S,E)-methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hydroxypropyl)benzoate
12/31/2013US8617845 Sequence diversity generation in immunoglobulins
12/31/2013US8617844 Use of cytokine receptors as biomarkers and therapeutic targets in human cancer
12/31/2013US8617841 Protein and production process and use thereof
12/31/2013US8617838 Fluorescent proteins and related methods and compounds
12/31/2013US8617822 Method of inhibiting binding or activity of MIF by administering a MIF antagonist
12/31/2013US8617813 Methods for modulating embryonic stem cell differentiation
12/31/2013US8617807 Nucleic acid binding proteins
12/31/2013US8617805 Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture
12/31/2013US8617575 Methods for conferring immunity against protozoans in an animal
12/31/2013US8617565 Surface exposed Haemophilus influenzae protein (protein E; pE)
12/31/2013US8617560 Peptides for vaccination against human CMV
12/31/2013US8617554 Anti-human CD52 immunoglobulins
12/31/2013US8617551 Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodies
12/31/2013US8617547 Methods and compositions for diagnosing prostate cancer
12/31/2013US8617535 Cytotherapeutics, cytotherapeutic units and methods for treatments using them
12/31/2013US8617534 Compositions and method for manipulating PIM-1 activity in circulatory system cells
12/31/2013US8617533 Multi-antigenic alphavirus replicon particles and methods
12/31/2013CA2722364C Melanoma antigens
12/31/2013CA2707266C Recombinantly modified plasmin
12/31/2013CA2602594C Directed complementation
12/31/2013CA2594358C Improving embryo development and survival
12/31/2013CA2543257C Methods and compositions for delivering polynucleotides
12/31/2013CA2542269C Fusion molecules comprising antigens and mhc i or ii cytoplasmic domains
12/31/2013CA2526935C Production of polyunsaturated fatty acids in oleaginous yeasts
12/31/2013CA2500033C Methods for isolation of bacteria from biological samples
12/31/2013CA2485847C Glucan-based vaccines
12/31/2013CA2478371C Compositions and methods for generating an immune response
12/31/2013CA2467908C Mfg-e8-l regulates phagocytic removal of apoptotic cells by macrophages
12/31/2013CA2426030C Methods of treating disorders related to apoe
12/31/2013CA2421584C Gene therapy for cardiac arrythmias
12/31/2013CA2407396C Use of the maize x112 mutant ahas 2 gene and imidazolinone herbicides for selection of transgenic monocots
12/31/2013CA2246768C Uses of gdnf and gdnf receptor
12/27/2013WO2013192613A2 Pvy resistance
12/27/2013WO2013192570A1 System and methods for genetic analysis of mixed cell populations
12/27/2013WO2013192545A1 Compositions and methods for mediating plant stomatal development in response to carbon dioxide and applications for engineering drought tolerance in plants
12/27/2013WO2013192520A1 Engineered microbes and methods for microbial oil overproduction from cellulosic materials
12/27/2013WO2013192486A1 Inhibitors of the mir-15 family of micro-rnas
12/27/2013WO2013192339A1 Biomarkers for the immunoediting-escape phase
12/27/2013WO2013192316A1 Genetically modified animals and methods for making the same
12/27/2013WO2013192294A1 Cellular therapies for treating and preventing cancers and other immune system disorders
12/27/2013WO2013192278A1 Gene targeting in plants using dna viruses
12/27/2013WO2013192277A2 Constructs and methods involving genes encoding glutamate receptor polypeptides
12/27/2013WO2013192256A1 Biological control of coleopteran pests
12/27/2013WO2013192237A1 Escherichia coli engineered for isobutyraldehyde production
12/27/2013WO2013192233A1 Compounds and method for improved cellular uptake of antisense compounds
12/27/2013WO2013192185A1 Methods compositions related to the smchd1 gene
12/27/2013WO2013192081A1 Terminating flower (tmf) gene and methods of use
12/27/2013WO2013191997A1 Expression of maize codon optimized proteins in pseudomonas fluorescens
12/27/2013WO2013191950A2 Unique modular vector design
12/27/2013WO2013191906A1 OPTIMIZATION OF EXPRESSION AND PURIFICATION OF RECOMBINANT HUMAN MxA PROTEIN IN E. COLI
12/27/2013WO2013191769A1 Genome editing
12/27/2013WO2013191651A1 An expression construct for sensing cell density and substrate availability and its use in conversion of hydroxycinnamic acids
12/27/2013WO2013191637A1 Method and device for efficient calculation of allele ratio confidence intervals and uses thereof
12/27/2013WO2013191591A1 Chimeric protein vaccine against pneumonia caused by streptococcus pneumoniae
12/27/2013WO2013191567A1 Recombinant microorganisms make biodiesel
12/27/2013WO2013191512A1 Method for preparing patient-specific glioblastoma animal model, and use thereof
12/27/2013WO2013191490A1 Method for producing 4-coumaric acid, caffeic acid, and ferulic acid through artificial metabolic pathway in high tyrosine-producing strain
12/27/2013WO2013191473A1 Method for screening for high l-tryptophan producing microorganisms using riboswitch
12/27/2013WO2013191400A1 Method for designing fusion primer for next generation sequencing, fusion primer, and method for analyzing genotype of target gene using next generation sequencing
12/27/2013WO2013191369A1 Hpgas1 gene-disrupted yeast strain and production method for recombinant protein using same
12/27/2013WO2013191349A1 Thermococcus onnurineus na1 mutant strain with increased hydrogen productivity, and method for producing hydrogen using same
12/27/2013WO2013191326A1 Microrna for checking whether human body is exposed to toluene, and checking method using same
12/27/2013WO2013191280A1 Agent for treating or preventing systemic inflammatory response syndrome
12/27/2013WO2013191242A1 Test method and treatment means for small cell lung cancer having poor prognosis
12/27/2013WO2013191225A1 Mucosal immunity-stimulating agent, and oral pharmaceutical composition for treating hpv infection
12/27/2013WO2013191223A1 Nucleic acid complex and nucleic acid-polysaccharide complex
12/27/2013WO2013191199A1 Method for improving protein rapidly
12/27/2013WO2013191197A1 Method for detecting nucleic acid and nucleic acid detection kit
12/27/2013WO2013191138A1 Method for producing trans-3-hydroxy-l-proline
12/27/2013WO2013190720A1 Technique for regulating sugar cane flowering
12/27/2013WO2013190679A1 Fusion protein, nucleic acid, vector, cell, method for measuring lab, and kit for use in measurement of lab
12/27/2013WO2013190630A1 Cell culturing vessel, and cell culturing method and automated cell culturing device using same
12/27/2013WO2013190399A1 Plants having enhanced yield-related traits and method for making same
12/27/2013WO2013190322A1 Regulation of seed dormancy
12/27/2013WO2013190059A1 Widespread gene delivery of gene therapy vectors
12/27/2013WO2013190032A1 Site-specific integration
12/27/2013WO2013189984A2 Plants having increased tolerance to herbicides
12/27/2013WO2013189878A1 Promoters for expressing a gene in a cell
12/27/2013WO2013189843A1 Genome sequence based targeted cloning of dna fragments
12/27/2013WO2013189611A1 Poxviral vectors for low antibody response after a first priming immunization
12/27/2013WO2013189309A1 Microparticle comprising functional microrna/sirna and application thereof
12/27/2013WO2013189047A1 Plant microrna identification and application thereof
12/27/2013WO2013189015A1 Snp markers associated with polycystic ovary syndrome
12/27/2013WO2013189004A1 Peptide nucleic acid of porcine reproductive and respiratory syndrome virus and uses thereof
12/27/2013WO2013189003A1 Peptide nucleic acid of subgroup j avian leukosis virus and uses thereof
12/27/2013WO2013188918A1 Improved recombinant viruses
12/27/2013WO2013166186A8 Method for determining complete response to anticancer therapy
12/27/2013WO2013143700A3 Artificial nucleic acid molecules comprising a 5'top utr
12/27/2013WO2013142859A3 Fusion proteins of superfolder green fluorescent protein and use thereof
12/27/2013WO2013124807A3 Oligonucleotides for modulating gene expression and uses thereof
12/27/2013WO2012170957A8 Retinoid-liposomes for enhancing modulation of hsp47 expression
12/27/2013CA2877496A1 Terminating flower (tmf) gene and methods of use
12/27/2013CA2877428A1 Widespread gene delivery of gene therapy vectors
12/27/2013CA2877297A1 Genetically modified animals and methods for making the same
12/27/2013CA2877290A1 Gene targeting in plants using dna viruses
12/27/2013CA2877236A1 Method for detecting nucleic acid and nucleic acid detection kit